Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200055168Phase 4Recruiting
Phase 4, randomised, open-label trial in irritable bowel syndrome (IBS) and Insomnia comparing Alprazolam arm with Placebo arm (2 arms). Primary endpoints: Functional magnetic resonance imaging of the brain, Serum cortisol and 1 more. Started Sep 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200055168.